Literature DB >> 3004961

Hormonal regulation of cell surface expression of the major histocompatibility antigen H-2Ld in transfected cells.

H Ponta, R Ball, M Steinmetz, B Groner.   

Abstract

The murine major histocompatibility antigens are cell surface glycoproteins which play an important role in the recognition of foreign antigens by cytotoxic T lymphocytes. Modulation of the level of expression of histocompatibility antigens could therefore be useful for the study of the interaction between the antigen presenting cells and T lymphocytes. The glucocorticoid hormone-inducible promoter, located in the long terminal repeat of mouse mammary tumor virus, was used to replace the promoter region of a cloned H-2Ld class I gene. The chimeric gene was introduced into cultured cells. Glucocorticoid induction of MMTV LTR H-2Ld mRNA could be shown by blot analysis. An S1 nuclease protection assay indicated that the transfected cells accurately initiate the chimeric mRNA. Immunoprecipitation of H-2Ld protein with a specific monoclonal antibody showed inducibility also at the cellular protein level. Fluorescence-activated cell sorter analysis monitored a 3-fold increase of H-2Ld on the cell surface when the transfected cells were grown in the presence of dexamethasone. This increase of H-2Ld expression was accompanied by a corresponding decrease on the cell surface of the endogenous H-2Kk.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004961      PMCID: PMC554683          DOI: 10.1002/j.1460-2075.1985.tb04103.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

Review 2.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

3.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

Review 4.  Expression of proviral DNA of mouse mammary tumour virus and its transcriptional control sequences.

Authors:  B Groner; B Salmons; W H Günzburg; N E Hynes; H Ponta
Journal:  Oxf Surv Eukaryot Genes       Date:  1984

5.  Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex.

Authors:  K Ozato; T H Hansen; D H Sachs
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

6.  Selection of rat hepatoma cells defective in hormone-regulated production of mouse mammary tumor virus RNA.

Authors:  J R Grove; G M Ringold
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Number and location of mouse mammary tumor virus proviral DNA in mouse DNA of normal tissue and of mammary tumors.

Authors:  B Groner; N E Hynes
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

8.  Hormone-responsive expression of an endogenous proviral gene of mouse mammary tumor virus after molecular cloning and gene transfer into cultured cells.

Authors:  N E Hynes; N Kennedy; U Rahmsdorf; B Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains.

Authors:  M Steinmetz; K W Moore; J G Frelinger; B T Sher; F W Shen; E A Boyse; L Hood
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

View more
  7 in total

1.  Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes.

Authors:  U H Koszinowski; M J Reddehase; G M Keil; J Schickedanz
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

2.  Posttranscriptional regulation of c-fos mRNA expression.

Authors:  H J Rahmsdorf; A Schönthal; P Angel; M Litfin; U Rüther; P Herrlich
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

3.  Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes.

Authors:  M J Reddehase; M R Fibi; G M Keil; U H Koszinowski
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

4.  The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.

Authors:  R Jaggi; B Salmons; D Muellener; B Groner
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

5.  Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Rafaela Holtappels; Sina I Schader; Oliver Oettel; Jürgen Podlech; Christof K Seckert; Matthias J Reddehase; Niels A W Lemmermann
Journal:  Front Cell Infect Microbiol       Date:  2020-04-15       Impact factor: 5.293

Review 6.  Viral hepatitis in pregnancy.

Authors:  Mohamed Tarek M Shata; Helal F Hetta; Yeshika Sharma; Kenneth E Sherman
Journal:  J Viral Hepat       Date:  2022-07-07       Impact factor: 3.517

7.  Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line.

Authors:  R K Ball; R R Friis; C A Schoenenberger; W Doppler; B Groner
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.